Advances in Chemistry and Pharmacology of Triterpenoid Synthetic Dimers

Author(s): Barbara Bednarczyk-Cwynar*, Andrzej Günther

Journal Name: Current Medicinal Chemistry

Volume 24 , Issue 20 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


This review focuses on advances in chemistry and pharmacology of synthetic triterpenoid dimers, obtained from natural compounds. Synthetic triterpenoid dimers are divided into specific subgroups based on the structure of main triterpenoid monomeric skeleton. Synthetic triterpenoid derivatives of dimeric structure can be obtained through the covalent linkage of the C-3 hydroxyl or another group, via the C-2 atom or the C-17 carboxyl group (mainly anhydrides, amides or esters). Some triterpenes can undergo chemical transformations leading to the formation of cyclic dimers or other types of dimers. Most of the obtained triterpenoid dimers have been subjected to pharmacological tests evaluating their biological activity, mainly antiviral (HIV-1 RT, HCVpp, VSVpp, HIV-RT-C8166-CCR5), cytotoxic (against e.g. 388, MCF-7, SF-268, NCIH460, KM20L2, DU-145, Hep-G2, A549, BGC-823, PC-3), anti-inflammatory (iNOS, RAW 264.7) and antidiabetic (RMGPa inhibition). The authors also reported the ability of some of the obtained cyclic triterpenoid dimers to recognize anions and to form self-assembled structures.

Keywords: Triterpenes, triterpenoid dimers, dimerization, synthetic dimers, derivatives of triterpenes, pharmacological activity of triterpenes.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 23 August, 2017
Page: [2205 - 2240]
Pages: 36
DOI: 10.2174/0929867324666170202151625
Price: $65

Article Metrics

PDF: 26
PRC: 2